SMITHKLINE BEECHAM's EMINASE WILL BE AVAILABLE AFTER JAN. 1, BACKED BY 1,200 BEECHAM, SK&F AND UPJOHN SALES REPS; THROMBOLYTIC APPROVED ON NOV. 27

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".